Mesa Laboratories, Inc. to Announce Fourth Quarter and Full Fiscal Year Results on May 27, 2026
Rhea-AI Summary
Mesa Laboratories (NASDAQ:MLAB) will release fourth-quarter and full fiscal year 2026 financial results on Wednesday, May 27, 2026 at approximately 6:00 A.M. ET. The company will issue a press release covering results for the quarter and fiscal year ended March 31, 2026.
Positive
- None.
Negative
- None.
News Market Reaction – MLAB
In the May 5 session, MLAB gained 0.84%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Dec 03 | Earnings date notice | Neutral | +1.0% | Announcement of Q3 FY26 earnings release timing and distribution details. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Prior earnings date scheduling news was followed by a modestly positive price reaction, suggesting a historically neutral-to-slightly-positive response to similar calendar announcements.
Recent news flow for Mesa Laboratories shows routine corporate and financial communication. A prior earnings date notice for third-quarter results on February 3, 2026 was associated with a +1.01% one-day move, indicating a mild positive reaction to scheduling information. Subsequent items in the broader history include regular quarterly dividends and operating results, but earnings-date announcements themselves have not been major volatility catalysts based on the limited tag-specific history available.
AI-generated analysis. How Rhea-AI works. Not financial advice.
LAKEWOOD, Colo., May 05, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the fourth quarter and the fiscal year ended March 31, 2026 at approximately 6:00 A.M. Eastern Time (ET) on Wednesday, May 27, 2026.
About Mesa Laboratories
Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increase patient and worker safety, and improve the quality of life throughout the world.
Mesa Laboratories Contacts
Siddhartha Kadia, President and CEO
John Sakys, Vice President and CFO
1-303-987-8000
For more information about Mesa Laboratories, please visit our website at www.mesalabs.com.